微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 54.15% | 9.73% | -40.35% | 69/157 | 50.55% | 泽璟制药 | 94.64% | 行业排名> |
| 2025-12-31 | 90.78% | -4.9% | -2.45% | 6/157 | 50.61% | 海创药业 | 99.82% | 行业排名> |
| 2025-09-30 | 93.06% | -3.96% | 84.68% | 5/157 | -2.2% | 海创药业 | 98.62% | 行业排名> |
| 2025-06-30 | 50.39% | -48.58% | 2.11% | 69/157 | 14.83% | 海创药业 | 99.57% | 行业排名> |
| 2025-03-31 | 49.35% | -50.11% | -48.3% | 68/157 | 31.96% | 海创药业 | 99.52% | 行业排名> |
| 2024-12-31 | 95.46% | 61.27% | -1.48% | 5/157 | 51.88% | 艾力斯 | 96.74% | 行业排名> |
| 2024-09-30 | 96.9% | 57.41% | -1.12% | 2/157 | 22.51% | 首药控股 | 98.96% | 行业排名> |
| 2024-06-30 | 97.99% | 53.37% | -0.94% | 1/157 | 33.12% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-03-31 | 98.92% | 59.45% | 67.12% | 1/157 | 51.76% | 百利天恒 | 97.99% | 行业排名> |
| 2023-12-31 | 59.19% | -11.53% | -3.84% | 57/157 | 51.61% | 百利天恒 | 98.92% | 行业排名> |
| 2023-09-30 | 61.56% | -10.14% | -3.66% | 50/157 | 32.47% | 迈威生物 | 98.93% | 行业排名> |
| 2023-06-30 | 63.89% | -10.77% | 2.99% | 46/157 | 38.42% | 迈威生物 | 99.59% | 行业排名> |
| 2023-03-31 | 62.04% | 2% | -7.28% | 49/157 | 52.97% | 迈威生物 | 99.8% | 行业排名> |
| 2022-12-31 | 66.91% | -11.01% | -2.33% | 45/157 | 53.83% | 迈威生物 | 99.46% | 行业排名> |
| 2022-09-30 | 68.5% | 2% | -4.34% | 39/157 | 5.64% | 迈威生物 | 99.75% | 行业排名> |
| 2022-06-30 | 71.61% | -8.93% | -4.75% | 39/157 | 20.99% | 迈威生物 | 99.67% | 行业排名> |
| 2021-12-31 | 75.18% | -6.21% | -4.38% | 33/157 | 55.2% | 迈威生物 | 99.44% | 行业排名> |
| 2021-06-30 | 78.63% | 26.22% | -1.91% | 24/157 | 47.23% | 迈威生物 | 98.57% | 行业排名> |
| 2020-12-31 | 80.16% | -0.98% | -0.98% | 22/157 | -148.64% | 首药控股 | 99.93% | 行业排名> |
| 2019-12-31 | 80.95% | 2.5% | 2.5% | 16/157 | -1242.15% | 艾力斯 | 99.41% | 行业排名> |
| 2018-12-31 | 78.98% | 2% | 26.78% | 23/157 | -211.97% | 艾力斯 | 98.7% | 行业排名> |